Topics

Drug Safety Communication: Belviq, Belviq XR (lorcaserin) by Eisai - FDA Requests Withdrawal of Weight-Loss Drug

07:00 EST 13 Feb 2020 | Drugs.com

Audience: Patient, Health Professional, Pharmacy ISSUE: FDA has requested that the manufacturer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market because a safety clinical trial shows an increased...

Original Article: Drug Safety Communication: Belviq, Belviq XR (lorcaserin) by Eisai - FDA Requests Withdrawal of Weight-Loss Drug

NEXT ARTICLE

More From BioPortfolio on "Drug Safety Communication: Belviq, Belviq XR (lorcaserin) by Eisai - FDA Requests Withdrawal of Weight-Loss Drug"

Quick Search

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...